Select longer-acting glucocorticoids for specific cases
STEP 1 — Gather Information
Collect diagnosis of adrenal insufficiency requiring glucocorticoid replacement; current glucocorticoid formulation and dosing schedule; patient-reported adherence challenges; availability of hydrocortisone formulations; patient lifestyle and preference for dosing frequency; any contraindications to specific longer-acting GCs (e.g., pregnancy for dexamethasone).
STEP 2 — Rule In / Rule Out
Is the patient requiring glucocorticoid replacement for adrenal insufficiency? If no, do not apply this skill; if yes, proceed to assess suitability for longer-acting GC.
STEP 3 — Classify or Stratify
Assess for circumstances favoring longer-acting GC: nonavailability of hydrocortisone, poor compliance with divided doses, or desire for once-daily convenience. If any present, classify as candidate for longer-acting GC; otherwise, continue with standard hydrocortisone.
STEP 4 — Decide
For candidates, select an appropriate longer-acting glucocorticoid (e.g., prednisone 5 mg daily or dexamethasone 0.5 mg daily) based on potency equivalence and patient factors; otherwise, prescribe hydrocortisone 15–20 mg daily in divided doses.
Clinical Guardrails / Mimics / Pitfalls
Avoid dexamethasone in pregnancy due to placental transfer; monitor for signs of over- or under-replacement (weight changes, glucose, blood pressure); do not use longer-acting GCs if patient requires stress dosing flexibility; ensure patient education on emergency glucocorticoid administration; avoid in patients with known hypersensitivity.
Concrete Clinical Example
A 45-year-old woman with secondary adrenal insufficiency works night shifts and misses afternoon hydrocortisone doses. She reports poor compliance with twice-daily HC. After confirming need for GC replacement and lack of contraindications, prescribe prednisone 5 mg once daily (equivalent to HC 20 mg) and provide stress-dose instructions.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118